Sports medicine company Fusionetics reported on Friday the receipt of capital investment from Stella Development.
According to Fusionetics, it will use the capital primarily to fuel growth of its Fusionetics system in the health care sector. Its performance health system is revolutionizing how technology can intersect with health care. It is designed to reduce injuries, decrease pain, optimize performance and speed recovery by turning complex science into simple, efficient and results-oriented applications accessible through a computer or personal digital device.
When paired with Stella's expertise in developing, deploying and scaling innovative capabilities within health care, Fusionetics' preventative solutions now have the potential to benefit self-insured employers, health plans, hospital systems and providers across the country.
Based in Minnesota, Stella is designed to nurture and scale differentiated businesses across the country to improve health in bold and innovative ways. It serves as the parent company for health insurer Blue Cross and Blue Shield of Minnesota and its subsidiaries and affiliate companies including Further and ClearStone Solutions Inc.
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Antin to acquire clinical trial equipment provider Emsere
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system